Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Ophthalmology ; 127(2): 230-237, 2020 02.
Article in English | MEDLINE | ID: mdl-31519386

ABSTRACT

PURPOSE: To compare serum vitamin D levels and patterns of ultraviolet light and dietary exposure among patients with active and inactive noninfectious uveitis and population controls. DESIGN: Prospective case-control study. All participants (n = 151) underwent serum 25-hydroxy vitamin D measurement and completed a questionnaire on vitamin D intake and ultraviolet light exposure. Serum 25-hydroxy vitamin D levels were compared between active and inactive uveitis groups and with local population estimates. PARTICIPANTS: Adult patients with active and inactive noninfectious uveitis were recruited from 2 Victorian tertiary hospitals and 1 private ophthalmic practice. METHODS: Serum 25-hydroxy vitamin D levels were compared between patients with active and inactive uveitis and population-based estimates of serum 25-hydroxy vitamin D levels, stratified by geographic region and season. Vitamin D intakes and exposures based on questionnaire results, including vitamin D supplementation and sunlight exposures on weekdays and weekends, were compared between active and inactive uveitis groups. MAIN OUTCOME MEASURES: Serum vitamin D levels, intake of vitamin D, and exposure to sources of vitamin D. RESULTS: The median level of serum vitamin D in those with active uveitis (n = 74) was 46 nmol/l (interquartile range [IQR], 29-70 nmol/l), significantly lower than in the inactive control group (n = 77) at 64 nmol/l (IQR, 52-79 nmol/l; P < 0.001). The active uveitis group also showed lower median serum vitamin D levels than the local population median of 62 nmol/l (IQR, 46-77 nmol/l). Vitamin D supplementation also was associated significantly with uveitis inactivity (P = 0.026, Kendall's τ test). In a subanalysis of vitamin D-deficient participants, sun exposure was associated significantly with uveitis inactivity (P = 0.014 for weekday and weekend analyses). CONCLUSIONS: Participants with active uveitis showed significantly lower serum 25-hydroxy vitamin D levels than inactive uveitis patients and local population-based estimates. Vitamin D supplementation was found to be associated with decreased uveitis activity, as was sun exposure in those with vitamin D deficiency. These results suggest that vitamin D supplementation should be studied as an option for the prevention of uveitis relapse in at-risk patients.


Subject(s)
Environmental Exposure , Ultraviolet Rays , Uveitis/blood , Vitamin D Deficiency/blood , Vitamin D/analogs & derivatives , Vitamin D/administration & dosage , Adult , Case-Control Studies , Female , Humans , Male , Middle Aged , Prospective Studies , Seasons , Surveys and Questionnaires , Uveitis/diagnosis , Uveitis/drug therapy , Uveitis/microbiology , Vitamin D/blood , Vitamin D Deficiency/diagnosis , Vitamin D Deficiency/drug therapy
2.
Invest Ophthalmol Vis Sci ; 60(1): 420-429, 2019 01 02.
Article in English | MEDLINE | ID: mdl-30695094

ABSTRACT

Purpose: We determine the changes in intestinal microbiota and/or disruptions in intestinal homeostasis during uveitis. Methods: Experimental autoimmune uveitis (EAU) was induced in B10.RIII mice with coadministration of interphotoreceptor retinoid-binding protein peptide (IRBP) and killed mycobacterial antigen (MTB) as an adjuvant. Using 16S rRNA gene sequencing, we looked at intestinal microbial differences during the course of uveitis, as well as intestinal morphologic changes, changes in intestinal permeability by FITC-dextran leakage, antimicrobial peptide expression in the gastrointstinal tract, and T lymphocyte prevalence before and at peak intraocular inflammation. Results: We demonstrate that increased intestinal permeability and antimicrobial peptide expression in the intestinal tract coincide in timing with increased effector T cells in the mesenteric lymph nodes, during the early stages of uveitis, before peak inflammation. Morphologic changes in the intestine were most prominent during this phase, but also occurred with adjuvant MTB alone, whereas increased intestinal permeability was found only in IRBP-immunized mice that develop uveitis. We also demonstrate that the intestinal microbiota were altered during the course of uveitis, and that some of these changes are specific to uveitic animals, whereas others are influenced by adjuvant MTB alone. Intestinal permeability peaked at 2 weeks, coincident with an increase in intestinal bacterial strain differences, peak lipocalin production, and peak uveitis. Conclusions: An intestinal dysbiosis accompanies a disruption in intestinal homeostasis in autoimmune uveitis, although adjuvant MTB alone promotes intestinal disruption as well. This may indicate a novel axis for future therapeutic targeting experimentally or clinically.


Subject(s)
Autoimmune Diseases/microbiology , Dysbiosis/microbiology , Gastrointestinal Microbiome/immunology , Homeostasis/physiology , Intestines/physiology , Uveitis/microbiology , Animals , Antigens, Bacterial/immunology , Autoimmune Diseases/immunology , Enzyme-Linked Immunosorbent Assay , Eye Proteins , Flow Cytometry , Lipocalins/metabolism , Mice , Mice, Mutant Strains , Models, Animal , Mycobacterium tuberculosis/genetics , Mycobacterium tuberculosis/immunology , RNA, Ribosomal, 16S/genetics , Retinol-Binding Proteins , Reverse Transcriptase Polymerase Chain Reaction , T-Lymphocyte Subsets/immunology , Uveitis/immunology , Zonula Occludens-1 Protein/metabolism
3.
J Pak Med Assoc ; 68(4): 653-656, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29808061

ABSTRACT

Leprosy is a chronic granulomatous disease involving the skin and nerves, leading to a debilitating condition. Leprosy has been controlled in most parts of the world; therefore physicians are not very well versed in the recognition, management and assessment of this disease. The protean manifestations of leprosy often lead to delays in diagnosis and increase the morbidity. We present a case of a 33-year-old male with fever, lymphadenopathy, nodular skin lesions, uveitis and arthritis. Lymphnode, bonemarrow and skin biopsy revealed 3+ AFB smear with negative AFB cultures, leading to the diagnosis of leprosy. The course of illness was complicated by flare of Erythema Nodosum Leprosum (ENL).


Subject(s)
Erythema Nodosum/microbiology , Fever/microbiology , Leprosy, Lepromatous/complications , Leprosy, Lepromatous/diagnosis , Adult , Arthritis/microbiology , Chronic Disease , Humans , Lymphadenopathy/microbiology , Male , Uveitis/microbiology
5.
Rev. bras. oftalmol ; 75(4): 322-324, July-Aug. 2016. graf
Article in English | LILACS | ID: lil-794863

ABSTRACT

ABSTRACT We describe an unusual case of Nocardia spp scleritis in a health girl resistant to topical fourth-generation fluoroquinolones. Clinically, there was only partial response of the scleritis to initial therapy. Treatment was changed to meropenem intravenously and topical amikacin. Following several weeks of antibiotic treatment, the patient's infection resolved but her vision was reduced to no light perception. Nocardia asteroides must be considered as a possible agent in cases of necrotizing scleritis in patients without a clear source. Antibiotic sensitivity testing has a definitive role in view of the resistance to these new medications.


RESUMO Nós descrevemos um raro caso de esclerite por Nocardia spp em uma criança sadia resistente a utilização tópica de fluorquinolona de quarta-geração. Clinicamente, a paciente apresentou apenas uma resposta parcial do quadro de esclerite a terapêutica inicial. O tratamento foi então modificado para meropenem intravenoso e amicacina tópica. Após várias semanas de tratamento com antibiótico, o quadro infeccioso regrediu porém a visao da pacientes evoluiu para perda da percepção luminosa. Em casos de esclerite necrotizante em pacientes sem fatores de risco aparente é necessário considerer a Nocardia Asteroides como possível agente causador. Os testes de sensibilidade medicamentosa apresentam importância significativa em virtude do aparecimento de resistência aos novos medicamentos.


Subject(s)
Humans , Female , Child , Uveitis/microbiology , Scleritis/microbiology , Fluoroquinolones/therapeutic use , Drug Resistance, Bacterial , Nocardia asteroides/isolation & purification , Nocardia Infections/drug therapy , Oxacillin/therapeutic use , Sulfamethoxazole/therapeutic use , Trimethoprim/therapeutic use , Uveitis/diagnosis , Uveitis/drug therapy , Prednisolone/therapeutic use , Amikacin/therapeutic use , Ciprofloxacin/therapeutic use , Microbial Sensitivity Tests , Eye Infections , Scleritis/diagnosis , Scleritis/drug therapy , Slit Lamp , Moxifloxacin/therapeutic use , Meropenem/therapeutic use , Anti-Bacterial Agents/therapeutic use , Nocardia Infections/diagnosis
6.
J Neuroimmunol ; 263(1-2): 98-107, 2013 Oct 15.
Article in English | MEDLINE | ID: mdl-24029580

ABSTRACT

We report here identification of novel mimicry epitopes for interphotoreceptor retinoid-binding protein (IRBP) 201-216, a candidate ocular antigen that causes experimental autoimmune uveoretinitis (EAU) in A/J mice. One mimicry epitope from Ehrlichia canis (EHC), designated EHC 44-59, induced cross-reactive T cells for IRBP 201-216 capable of producing T helper (Th)1 and Th17 cytokines, but failed to induce EAU in A/J mice. In addition, animals first primed with suboptimal doses of IRBP 201-216 and subsequently immunized with EHC 44-59 did not develop EAU; rather, the mimicry epitope prevented the disease induced by IRBP 201-216. However, alteration in the composition of EHC 44-59 by substituting alanine with valine at position 49, similar to the composition of IRBP 201-216, enabled the mimicry epitope to acquire uveitogenicity. The data provide new insights as to how microbes containing mimicry sequences for retinal antigens can prevent ocular inflammation by acting as naturally occurring altered peptide ligands.


Subject(s)
Autoimmune Diseases of the Nervous System/prevention & control , Ehrlichia canis/immunology , Ehrlichiosis/prevention & control , Molecular Mimicry/immunology , Retinitis/prevention & control , Uveitis/prevention & control , Amino Acid Sequence , Animals , Autoimmune Diseases of the Nervous System/immunology , Autoimmune Diseases of the Nervous System/microbiology , Cattle , Ehrlichia canis/genetics , Ehrlichiosis/immunology , Ehrlichiosis/microbiology , Eye Proteins/administration & dosage , Eye Proteins/genetics , Eye Proteins/metabolism , Female , Ligands , Mice , Mice, Inbred A , Molecular Sequence Data , Retinitis/immunology , Retinitis/microbiology , Retinol-Binding Proteins/administration & dosage , Retinol-Binding Proteins/genetics , Retinol-Binding Proteins/metabolism , Uveitis/immunology , Uveitis/microbiology
7.
Ann N Y Acad Sci ; 1111: 404-10, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17303834

ABSTRACT

We report here the first documented case of ocular coccidioidomycosis in a chimpanzee (Pan troglodytes). In 1996, a 12-year-old female chimpanzee was undergoing treatment with an experimental triazole, BayR3783, for coccidioidomycosis when she was diagnosed with severe conjunctivitis in the right eye. Subsequent development of a coccidioidal granuloma of the ventral conjunctiva and anterior uvea was noted over the next several months, distorting the lens, iris, pupil, and sclera and progressing to uveitis. Treatment with BayR3783 and subconjunctival injections of triamcinolone were successful in reducing the ocular mass, but extensive damage was done to the lens and cornea. This case study provides an interesting comparison to ocular coccidioidomycosis cases observed in both humans and canines.


Subject(s)
Coccidioidomycosis/diagnosis , Coccidioidomycosis/therapy , Eye/microbiology , Uveitis/diagnosis , Uveitis/therapy , Animals , Coccidioides/metabolism , Coccidioidomycosis/microbiology , Coccidioidomycosis/veterinary , Conjunctivitis/diagnosis , Conjunctivitis/microbiology , Conjunctivitis/therapy , Conjunctivitis/veterinary , Female , Ketoconazole/therapeutic use , Models, Anatomic , Pan troglodytes , Uveitis/microbiology , Uveitis/veterinary
9.
Ophthalmology ; 99(12): 1805-8, 1992 Dec.
Article in English | MEDLINE | ID: mdl-1336155

ABSTRACT

PURPOSE: A case of acyclovir-resistant herpes simplex virus keratouveitis after penetrating keratoplasty is reported. METHODS: Resistance to acyclovir was evident clinically and was confirmed by in vitro susceptibility testing. The susceptibility of the herpes simplex isolates to acyclovir and foscarnet was determined by a dye uptake assay that measured cytopathic effect, and thymidine kinase activity was measured by a plaque autoradiography technique. RESULTS: The viral isolate from postoperative day 22 was susceptible to acyclovir and foscarnet, and showed normal thymidine kinase activity. Isolates from postoperative days 29 and 32 (coinciding with deterioration in clinical appearance) were resistant to acyclovir, susceptible to foscarnet, and deficient in thymidine kinase activity. CONCLUSION: Practitioners should be aware of the potential for the emergence of resistance in this setting; prophylaxis and rational alternate therapies are discussed.


Subject(s)
Acyclovir/therapeutic use , Keratitis, Herpetic/drug therapy , Keratoplasty, Penetrating/adverse effects , Simplexvirus/drug effects , Uveitis/drug therapy , Acyclovir/pharmacology , Administration, Oral , Animals , Drug Resistance, Microbial , Foscarnet/pharmacology , Humans , Male , Microbial Sensitivity Tests , Middle Aged , Ophthalmic Solutions , Postoperative Complications , Simplexvirus/isolation & purification , Uveitis/microbiology , Vero Cells , Visual Acuity
10.
Br J Vener Dis ; 59(6): 373-5, 1983 Dec.
Article in English | MEDLINE | ID: mdl-6640262

ABSTRACT

We describe two patients, one with peripheral arthritis, sacro-iliitis, positive HLA B27, and autoantibodies to smooth muscle and gastric parietal cell; the other with aphthoid ulcers, geographical tongue, conjunctivitis, anterior uveitis, peripheral arthralgia, and diarrhoea with distal proctocolitis. Neither patient would have been diagnosed as having urethritis on the basis of accepted microscopic criteria. In both patients, however, Chlamydia trachomatis was isolated from the prostatic fluid, but not the urethra.


Subject(s)
Arthritis/microbiology , Chlamydia trachomatis/isolation & purification , Conjunctivitis/microbiology , Prostate/microbiology , Uveitis/microbiology , Adult , Arthritis, Reactive/microbiology , Body Fluids/microbiology , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL